In the UK, since 2009, a significant trend towards fewer hospitalisations for hypoglycaemia was recently reported among older adults (65–80 years) with type 2 diabetes, which may be explained by the decreasing use of sulfonylureas [ 77 ].
← all excerpts
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.
1
—
—